Canadian pets are a few steps closer to getting their paws on pot-based medical treatments in Canada as more cannabis companies research marijuana’s efficacy for companion animals.
Canopy Growth Corp. is the latest medical marijuana company to enter the potentially lucrative pet market with its announcement this week that it will embark on a Health Canada-approved clinical trial to research the use of cannabis-based products to treat animal anxiety.
The Canadian Veterinary Medical Association’s Dr. Shane Renwick says there’s been a flurry of cannabis-related pet health research as Canada’s laws on recreational cannabis crystallize ahead of legalization on Oct. 17.
The association’s national issues and animal welfare manager expects there to be more clinical trials in the pipeline going forward.
“We hope that there will be the research required to allow safe registered products on the market in the not-too-distant future… It will offer alternatives in a lot of cases to medications we’re currently using for a variety of conditions,” Renwick added. “So it’s an exciting potential that we see.”
Dr. Renwick said the association’s members have fielded many queries from clients asking about treating their pets ailments, such as pain, with cannabis. However, there is no legal avenue for veterinarians to prescribe pot, unlike for medical physicians, and not enough clinical evidence to support it, he added.